Biden administration to ask federal workers for proof of vaccination; CDC: 70% of U.S. counties should return to masking; Eli Lilly set to acquire Kumquat’s immuno-oncology franchise.
Five things for health marketers to know: Thursday, July 29, 2021
Biden administration reverses Trump policy limiting penalties for nursing home safety violations; NYC to provide $100 incentive for vaccination; FDA halts trial for Oncopeptides’ Pepaxto.
Five things for health marketers to know: Wednesday, July 28, 2021
CDC suggests fully vaccinated people wear masks indoors again; Calico partners with AbbVie on age-related diseases; Report: Biogen withdrew Aduhelm paper submitted to JAMA.
Five things for health marketers to know: Tuesday, July 27, 2021
Fauci pushes to develop new vaccines before next pandemic; PerkinElmer acquires BioLegend for $5.25 billion; Veterans Affairs mandates vaccines for most health workers.
Five things for health marketers to know: Monday, July 26, 2021
CDC: U.S. at ‘pivotal moment’ with Delta variant; Biogen launches consumer campaign on cognitive impairment; Google opens up DeepMind database to researchers.
Five things for health marketers to know: Friday, July 23, 2021
Pfizer spends $1 billion to expand Arvinas’ breast cancer program; White House sends $100 million to rural states experiencing COVID spikes; Happify Health launches depression treatment.
Five things for health marketers to know: Thursday, July 22, 2021
More hospitals requiring health workers to receive the COVID vaccine; state attorneys general reach $26 billion opioid settlement; Novartis ends program for dry eye drug.
Five things for health marketers to know: Wednesday, July 21, 2021
EU begins real-time review of Sanofi/GlaxoSmithKline vaccine; U.S. states sit on a surplus of millions of doses; Relmada Therapeutics spends $15 million for Arbormentis’ psychedelics.
Five things for health marketers to know: Tuesday, July 20, 2021
U.S. cases, deaths rise with spread of Delta variant; Surgeon General Murthy calls on Americans to fight health misinformation; Hospitals not compliant with pricing transparency rule.